MLYSMineralys Therapeutics Inc
MLYS
Mineralys Therapeutics Inc578
Mkt Cap
$2.19BVolume
983,354.0052W High
$47.6552W Low
$12.59PE Ratio
-11.19MLYS Fundamentals
Price
$26.62Prev Close
$27.17Open
$27.2550D MA
$27.59Beta
1.01Avg. Volume
1.43MEPS (Annual)
-$2.29P/B
3.36Rev/Employee
$0.00$1,798.61
Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Given Average Rating of "Moderate Buy" by Analysts
Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the eight analysts that are currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell rating, one has given a hold rating and six...
MarketBeat·2d ago
Insider Selling: Mineralys Therapeutics (NASDAQ:MLYS) CEO Sells 75,000 Shares of Stock
Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Get Free Report) CEO Jon Congleton sold 75,000 shares of the business's stock in a transaction that occurred on Tuesday, March 31st. The stock was sold at...
MarketBeat·9d ago
Insider Selling: Mineralys Therapeutics (NASDAQ:MLYS) Director Sells 3,000 Shares of Stock
Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Get Free Report) Director Daphne Karydas sold 3,000 shares of the business's stock in a transaction on Tuesday, March 31st. The stock was sold at an average price of $25.00, for a total transaction of $75,000.00. Following the completion of the...
MarketBeat·9d ago
Mineralys Therapeutics (NASDAQ:MLYS) CEO Jon Congleton Sells 75,000 Shares
Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Get Free Report) CEO Jon Congleton sold 75,000 shares of the company's stock in a transaction that occurred on Tuesday, March 31st. The stock was sold at an average price of $26.27, for a total transaction of $1,970,250.00. Following the completion of the...
MarketBeat·9d ago
Mineralys Therapeutics (NASDAQ:MLYS) Director Acquires $7,354,269.00 in Stock
Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Get Free Report) Director Ra Capital Management, L.P. acquired 310,700 shares of the company's stock in a transaction that occurred on Friday, March 27th. The shares were acquired at an average cost of $23.67 per share, with a total value of...
MarketBeat·10d ago
Notable Tuesday Option Activity: MLYS, DELL, SGHC
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Mineralys Therapeutics Inc (Symbol: MLYS), where a total volume of 8,817 contracts has been traded thus far today, a contract volume which is representative of a...
Nasdaq News: Markets·11d ago
Mineralys Therapeutics (NASDAQ:MLYS) Stock Price Up 12.4% - What's Next?
Mineralys Therapeutics (NASDAQ:MLYS) Stock Price Up 12.4% - Here's Why...
MarketBeat·11d ago
Investors Purchase High Volume of Mineralys Therapeutics Put Options (NASDAQ:MLYS)
Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Get Free Report) was the target of unusually large options trading on Tuesday. Traders acquired 23,052 put options on the company. This is an increase of approximately 295% compared to the typical daily volume of 5,832 put options...
MarketBeat·12d ago
SG Americas Securities LLC Buys 130,758 Shares of Mineralys Therapeutics, Inc. $MLYS
SG Americas Securities LLC raised its stake in Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Free Report) by 130.7% during the fourth quarter, according to its most recent disclosure with the...
MarketBeat·12d ago
Hudson Bay Capital Management LP Invests $2.87 Million in Mineralys Therapeutics, Inc. $MLYS
Hudson Bay Capital Management LP purchased a new stake in shares of Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 75,768 shares of the company's stock, valued at appr...
MarketBeat·21d ago
<
1
2
...
>